Knee Osteoarthritis Clinical Trial
Official title:
Clinical and Functional Effects of Kinesiotaping and Physiotherapy in Grade 2 Osteoarthritis Following Degenerative Meniscal Tears in Football Players - A Randomized Control Trial
Verified date | January 2024 |
Source | Prince Sattam Bin Abdulaziz University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Degenerative meniscal tears are a common cause of osteoarthritis commonly diagnosed in football players and are considered a major risk factor for the development of knee osteoarthritis. This study aimed to investigate the Clinical and functional effects of kinesiotaping and physiotherapy in grade 2 osteoarthritis following degenerative meniscal tears in football players.
Status | Completed |
Enrollment | 56 |
Est. completion date | August 30, 2023 |
Est. primary completion date | August 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: Diagnosis of Knee Osteoarthritis: Individuals with a confirmed diagnosis of knee osteoarthritis based on clinical and/or radiological assessments. Mild to Moderate Knee OA: Kinesiotaping may be more appropriate for individuals with mild to moderate knee OA rather than severe cases. Presence of Pain and Discomfort: Individuals experiencing pain, discomfort, or limitations in function related to knee osteoarthritis. Functional Limitations: Those with functional limitations in activities of daily living or reduced mobility due to knee OA. No Contraindications: Individuals without contraindications to kinesiotaping, such as skin allergies, infections, or open wounds in the application area. Willingness to Participate: Individuals who are willing to participate in and adhere to the kinesiotaping intervention. Not Responsive to Other Conservative Treatments: Those who have tried and not responded adequately to other conservative treatments for knee OA, such as exercise, physical therapy, or oral medications. Absence of Serious Comorbidities: Individuals without serious comorbidities or medical conditions that may contraindicate the use of kinesiotaping. Individual Preferences: Consideration of individual preferences and acceptance of kinesiotaping as part of the treatment plan. Exclusion Criteria: - 1. Skin Conditions: - Active skin infections, allergies, or open wounds in the area where kinesiotape is to be applied. - Skin conditions that may be aggravated or worsened by the adhesive in the tape. 2. Vascular Disorders: - Conditions that affect blood circulation, such as peripheral vascular disease, deep vein thrombosis, or other vascular disorders, which may be worsened by the application of kinesiotape. 3. Peripheral Neuropathy: - Individuals with peripheral neuropathy or other nerve disorders, as kinesiotaping may affect sensation, and there is a risk of injury or discomfort. 4. Cancer or Tumors: - Active cancer or tumors in the region where kinesiotape is to be applied, as kinesiotaping could interfere with cancer treatment or exacerbate symptoms. 5. Joint Instability: - Individuals with severe joint instability, as kinesiotape may not provide sufficient support for highly unstable joints. 6. Allergies to Tape Components: - Known allergies to the materials or adhesive used in kinesiotape. 7. Circulatory Disorders: - Severe circulatory disorders, which may be exacerbated by the pressure or tension applied by kinesiotape. |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | Saud Alrawilli | Al Kharj | Riyad |
Lead Sponsor | Collaborator |
---|---|
Gopal Nambi |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain intensity - Visual analog scale | The VAS is usually presented as a straight line, often 10 centimeters (or another standard length), with two endpoints representing extreme points on a continuum. For example, one end may be labeled "No Pain" or "No Symptoms," and the other end labeled "Worst Pain Imaginable" or "Maximum Symptoms." | Baseline | |
Primary | Pain intensity - Visual analog scale | The VAS is usually presented as a straight line, often 10 centimeters (or another standard length), with two endpoints representing extreme points on a continuum. For example, one end may be labeled "No Pain" or "No Symptoms," and the other end labeled "Worst Pain Imaginable" or "Maximum Symptoms." | 8 weeks | |
Primary | Pain intensity - Visual analog scale | The VAS is usually presented as a straight line, often 10 centimeters (or another standard length), with two endpoints representing extreme points on a continuum. For example, one end may be labeled "No Pain" or "No Symptoms," and the other end labeled "Worst Pain Imaginable" or "Maximum Symptoms." | 6 months | |
Secondary | Functional disability - WOMAC | The WOMAC scale consists of three subscales, each assessing a different dimension of health related to osteoarthritis. | Baseline | |
Secondary | Functional disability - WOMAC | The WOMAC scale consists of three subscales, each assessing a different dimension of health related to osteoarthritis. | 8 weeks | |
Secondary | Functional disability - WOMAC | The WOMAC scale consists of three subscales, each assessing a different dimension of health related to osteoarthritis. | 6 months | |
Secondary | Sports performance - Timed up and go test | Ask the individual to sit in the chair with their back against the backrest and their arms on the chair arms (if available). On the "go" signal, instruct them to stand up, walk around the first cone, return to the chair, and sit back down. Use a stopwatch to measure the time it takes for the individual to complete the task. Faster times generally indicate better agility and functional mobility. | Baseline | |
Secondary | Sports performance - Timed up and go test | Ask the individual to sit in the chair with their back against the backrest and their arms on the chair arms (if available). On the "go" signal, instruct them to stand up, walk around the first cone, return to the chair, and sit back down. Use a stopwatch to measure the time it takes for the individual to complete the task. Faster times generally indicate better agility and functional mobility. | 8 weeks | |
Secondary | Sports performance - Timed up and go test | Ask the individual to sit in the chair with their back against the backrest and their arms on the chair arms (if available). On the "go" signal, instruct them to stand up, walk around the first cone, return to the chair, and sit back down. Use a stopwatch to measure the time it takes for the individual to complete the task. Faster times generally indicate better agility and functional mobility. | 6 months | |
Secondary | Sports performance - 40 Metre zig zag test | Set up a zigzagging path using cones or markers. The path should be 40 meters in total length. The zigzag pattern should include sharp turns, requiring participants to change direction quickly. Explain the test to the participant, emphasizing the need to navigate through the zigzag path as quickly as possible.
Emphasize the importance of agility, speed, and quick changes in direction. Use a stopwatch or timer to measure the time it takes for the participant to complete the 40-meter zigzag course. On the "go" signal, the participant should start from the beginning and navigate through the zigzag path as quickly as possible. Time should be recorded when the participant crosses the finishing line. |
Baseline | |
Secondary | Sports performance - 40 Metre zig zag test | Set up a zigzagging path using cones or markers. The path should be 40 meters in total length. The zigzag pattern should include sharp turns, requiring participants to change direction quickly. Explain the test to the participant, emphasizing the need to navigate through the zigzag path as quickly as possible.
Emphasize the importance of agility, speed, and quick changes in direction. Use a stopwatch or timer to measure the time it takes for the participant to complete the 40-meter zigzag course. On the "go" signal, the participant should start from the beginning and navigate through the zigzag path as quickly as possible. Time should be recorded when the participant crosses the finishing line. |
8 weeks | |
Secondary | Sports performance - 40 Metre zig zag test | Set up a zigzagging path using cones or markers. The path should be 40 meters in total length. The zigzag pattern should include sharp turns, requiring participants to change direction quickly. Explain the test to the participant, emphasizing the need to navigate through the zigzag path as quickly as possible.
Emphasize the importance of agility, speed, and quick changes in direction. Use a stopwatch or timer to measure the time it takes for the participant to complete the 40-meter zigzag course. On the "go" signal, the participant should start from the beginning and navigate through the zigzag path as quickly as possible. Time should be recorded when the participant crosses the finishing line. |
6 months | |
Secondary | Quality of life - SF-12 | The Short Form Health Survey (SF-12) is a widely used and validated questionnaire designed to assess health-related quality of life (HRQoL) across various populations. It is a shorter version of the SF-36 and provides a quick and reliable measure of general health status. The SF-12 includes 12 questions covering eight health domains and yields two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). | Baseline | |
Secondary | Quality of life - SF-12 | The Short Form Health Survey (SF-12) is a widely used and validated questionnaire designed to assess health-related quality of life (HRQoL) across various populations. It is a shorter version of the SF-36 and provides a quick and reliable measure of general health status. The SF-12 includes 12 questions covering eight health domains and yields two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). | 8 weeks | |
Secondary | Quality of life - SF-12 | The Short Form Health Survey (SF-12) is a widely used and validated questionnaire designed to assess health-related quality of life (HRQoL) across various populations. It is a shorter version of the SF-36 and provides a quick and reliable measure of general health status. The SF-12 includes 12 questions covering eight health domains and yields two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |